1
Selvarajah, A., Tavenier, A. H., Bor, W. L., Houben, V., Rasoul, S., Kaplan, E., Teeuwen, K., Hofma, S. H., Lipsic, E., Amoroso, G., van Leeuwen, M. A. H., Berg, J. M. ten, van ‘t Hof, A. W. J., Hermanides, R. S.
Veröffentlicht in: BMC Cardiovascular Disorders ; volume 21, issue 1 ; ISSN 1471-2261;
2021
Veröffentlicht in: BMC Cardiovascular Disorders ; volume 21, issue 1 ; ISSN 1471-2261;
2021
2
Selvarajah, A., Tavenier, A. H., Bor, W. L., Houben, J.E.M., Rasoul, S., Kaplan, E., Teeuwen, K., Hofma, S. H., Lipsic, E., Amoroso, G., van Leeuwen, M. A. H., ten Berg, J. M., van 't Hof, A. W. J., Hermanides, R. S.
Veröffentlicht in: Selvarajah , A , Tavenier , A H , Bor , W L , Houben , J E M , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van 't Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention : rationale of the Dutch Cangrelor Registry ' , BMC Cardiovascular Disorders , vol. 21 , no. 1 , 292 . https://doi.org/10.1186/s12872-021-02093-4;
2021
Veröffentlicht in: Selvarajah , A , Tavenier , A H , Bor , W L , Houben , J E M , Rasoul , S , Kaplan , E , Teeuwen , K , Hofma , S H , Lipsic , E , Amoroso , G , van Leeuwen , M A H , ten Berg , J M , van 't Hof , A W J & Hermanides , R S 2021 , ' Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention : rationale of the Dutch Cangrelor Registry ' , BMC Cardiovascular Disorders , vol. 21 , no. 1 , 292 . https://doi.org/10.1186/s12872-021-02093-4;
2021